Frontiers in Glioma Pathobiology
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: closed (15 November 2022) | Viewed by 2630
Special Issue Editor
Interests: brain tumors; glioblastoma; diffuse midline glioma; genomics and molecular classification; signaling pathways; PTEN tumor suppressor; NHERF1; diagnostic markers; therapy targets; glioma epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Glioblastoma is a high-grade diffuse glioma and the most frequent primary intraparenchymal brain tumor. To this day, treatment is a challenge and survival relatively poor. Therapy resistance stems from the pathobiological characteristics of diffuse gliomas, starting from the sanctuary generated by the blood–brain barrier preventing drug and immune cell cytotoxicity to resistance to radiotherapy due to genetic, epigenetic, DNA damage response and signal transduction mechanisms, cancer cell invasiveness and interaction with the microenvironment, and tumor heterogeneity and reprogramming. It is now clear that the understanding of the mechanisms of glioma initiation and progression is key to effective treatment development. In this Special Edition, experts in the field are invited to share a brief overview of the current knowledge on diffuse glioma pathobiology, as well as to highlight their forefront research findings and propose actionable biological and molecular vulnerabilities for these tumors deriving from their own research.
Dr. Maria-Magdalena Georgescu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diffuse glioma/glioblastoma/diffuse astrocytoma/oligodendroglioma/diffuse midline glioma
- tumor initiation/cells of origin
- genetics/somatic and germline
- cell cycle/DNA damage response
- epigenetic control/telomere maintenance
- growth signaling pathways/metabolism
- tumor heterogeneity
- invasiveness/microenvironment/angiogenesis/immune response
